A 200mg/5mL strength of Suprax (cefixime) for oral suspension has been approved. A 100mg/5mL dosage strength is already available. Suprax for oral suspension is indicated for treating susceptible infections, including otitis media, pharyngitis, tonsillitis, acute bronchitis, acute exacerbation of chronic bronchitis; uncomplicated UTIs and cervical or urethral gonorrhea.

For more information call Lupin at (800) 399-2561 or visit www.lupinpharmaceuticals.com.